Ji Zhou

1.1k total citations · 1 hit paper
50 papers, 739 citations indexed

About

Ji Zhou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ji Zhou has authored 50 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ji Zhou's work include RNA modifications and cancer (5 papers), Immune cells in cancer (5 papers) and Ferroptosis and cancer prognosis (4 papers). Ji Zhou is often cited by papers focused on RNA modifications and cancer (5 papers), Immune cells in cancer (5 papers) and Ferroptosis and cancer prognosis (4 papers). Ji Zhou collaborates with scholars based in China, United States and Finland. Ji Zhou's co-authors include Min Xie, Bing Yao, Li Chen, Shengrong Chen, Zhiwei Hong, Jie Li, Hongjun Li, Tianyao Guo, Hongtao Gao and Zhen Guo and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Ji Zhou

45 papers receiving 726 citations

Hit Papers

Chrysotoxine regulates ferroptosis and the PI3K/AKT/mTOR ... 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ji Zhou China 16 309 115 93 93 79 50 739
Yaru Xu China 17 295 1.0× 70 0.6× 61 0.7× 80 0.9× 33 0.4× 57 758
Saswati Banerjee United States 13 257 0.8× 95 0.8× 50 0.5× 68 0.7× 33 0.4× 31 725
Zhaojun Zhang China 19 506 1.6× 89 0.8× 89 1.0× 127 1.4× 31 0.4× 67 1.1k
Ahmed Reda Egypt 13 402 1.3× 244 2.1× 192 2.1× 48 0.5× 53 0.7× 37 908
Yuanyuan Gao China 15 393 1.3× 64 0.6× 50 0.5× 239 2.6× 27 0.3× 41 772
Kun Wu China 20 551 1.8× 51 0.4× 32 0.3× 158 1.7× 91 1.2× 72 1.1k
Michael Knoll United States 17 421 1.4× 93 0.8× 160 1.7× 27 0.3× 41 0.5× 21 1.0k
Sun‐Young Yoon South Korea 14 194 0.6× 85 0.7× 69 0.7× 21 0.2× 27 0.3× 34 537
Davoud Jafari-Gharabaghlou Iran 17 355 1.1× 35 0.3× 34 0.4× 82 0.9× 80 1.0× 42 871
Lisa A. McConnachie United States 15 207 0.7× 30 0.3× 66 0.7× 45 0.5× 36 0.5× 25 689

Countries citing papers authored by Ji Zhou

Since Specialization
Citations

This map shows the geographic impact of Ji Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Zhou more than expected).

Fields of papers citing papers by Ji Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ji Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Zhou. The network helps show where Ji Zhou may publish in the future.

Co-authorship network of co-authors of Ji Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Ji Zhou. A scholar is included among the top collaborators of Ji Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ji Zhou. Ji Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Ji, Jie Mei, Junli Ding, et al.. (2024). Lovastatin-mediated pharmacological inhibition of Formin protein DIAPH1 suppresses tumor immune escape and boosts immunotherapy response. International Immunopharmacology. 144. 113637–113637.
3.
Yao, Weiwei, Yucheng Zhang, Yongfeng Liu, et al.. (2024). LGALS9B stabilizes EEF1D protein and activates the PI3K/AKT signaling pathway to promote gastric cancer occurrence and metastasis. Oncogene. 44(10). 652–664.
6.
Zhou, Ji, Haoying Li, Ben Wu, et al.. (2024). Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer. Scientific Reports. 14(1). 1860–1860. 37 indexed citations
7.
Zhou, Ji, Zhenyu Guo, Ben Wu, et al.. (2024). Chrysotoxine regulates ferroptosis and the PI3K/AKT/mTOR pathway to prevent cervical cancer. Journal of Ethnopharmacology. 338(Pt 3). 119126–119126. 56 indexed citations breakdown →
8.
Mei, Jie, Rui Xu, Yun Cai, et al.. (2024). B7-H3 is associated with the armored-cold phenotype and predicts poor immune checkpoint blockade response in melanoma. Pathology - Research and Practice. 256. 155267–155267. 7 indexed citations
9.
Zhou, Ji, Tianyao Guo, Lin Zhou, et al.. (2023). The ferroptosis signature predicts the prognosis and immune microenvironment of nasopharyngeal carcinoma. Scientific Reports. 13(1). 1861–1861. 24 indexed citations
10.
Zhou, Ji, Yali Fan, Xiaomei Lv, et al.. (2022). Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors. European Journal of Medicinal Chemistry. 245(Pt 1). 114860–114860. 8 indexed citations
11.
Tang, Tong Boon, et al.. (2021). Potential and applications of capillary electrophoresis for analyzing traditional Chinese medicine: a critical review. The Analyst. 146(15). 4724–4736. 14 indexed citations
12.
Zhou, Ji, Peng Yang, Yingchun Gao, et al.. (2021). Targeting DNAJC19 overcomes tumor growth and lung metastasis in NSCLC by regulating PI3K/AKT signaling. Cancer Cell International. 21(1). 338–338. 6 indexed citations
13.
Li, Chen, Hancheng Qiu, Xianli Lv, et al.. (2021). Perforator preservation technologies (PPT) based on a new neuro-interventional classification in endovascular treatment of perforator involving aneurysms (piANs). Chinese Neurosurgical Journal. 7(1). 26–26. 1 indexed citations
14.
Pan, Shuting, Ji Zhou, Fang Yang, Shu‐Feng Zhou, & Tao Ren. (2020). Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells. BMC Cancer. 20(1). 634–634. 15 indexed citations
15.
Chen, Li, Haixiang Sun, Youbing Xia, et al.. (2016). Electroacupuncture decreases the progression of ovarian hyperstimulation syndrome in a rat model. Reproductive BioMedicine Online. 32(5). 538–544. 9 indexed citations
16.
Yi, Xin, et al.. (2014). The Proteasome Activator PA28γ, a Negative Regulator of p53, Is Transcriptionally Up-Regulated by p53. International Journal of Molecular Sciences. 15(2). 2573–2584. 15 indexed citations
17.
Wang, Heng, et al.. (2013). Gynura procumbens ethanolic extract suppresses osteosarcoma cell proliferation and metastasis in vitro. Oncology Letters. 6(1). 113–117. 23 indexed citations
18.
Wang, Shuzhi, Dao‐jian Gao, Rui Lü, et al.. (2011). A prospective randomized study on digestive tract cleaning before ERCP for the prevention of post- procedure cholangitis. Zhonghua xiaohua neijing zazhi. 28(10). 555–558. 2 indexed citations
19.
Xu, Jun, et al.. (2007). Immunohistochemical characterization of hepatic stem cell-related cells in developing human liver. Frontiers of Medicine in China. 1(3). 264–268. 3 indexed citations
20.
Zhou, Ji, et al.. (1988). Effects ofTripterygium hypoglaucum (Lévl.) Hutch on male fertility. Advances in Contraception. 4(4). 307–310. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026